{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:04:11Z","timestamp":1768550651173,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ijrobp.2010.07.031","type":"journal-article","created":{"date-parts":[[2010,11,18]],"date-time":"2010-11-18T04:30:20Z","timestamp":1290054620000},"page":"1236-1243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of Vascular Endothelial Growth Factor as a Prognostic Marker for Local Relapse in Early-Stage Breast Cancer Patients Treated With Breast-Conserving Therapy"],"prefix":"10.1016","volume":"81","author":[{"given":"Meena S.","family":"Moran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharad","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyndsay","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce G.","family":"Haffty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.07.031_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib2","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1200\/JCO.2005.01.186","article-title":"Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma","volume":"23","author":"Rini","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbrc.2005.07.145","article-title":"Vascular endothelial growth factor receptors in osteoclast differentiation and function","volume":"335","author":"Aldridge","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib4","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1158\/1078-0432.CCR-06-1008","article-title":"Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer","volume":"13","author":"Hefler","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10456-005-9001-1","article-title":"Angiogenesis in normal and neoplastic ovaries","volume":"8","author":"Ramakrishnan","year":"2005","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib6","first-page":"69","article-title":"EG-VEGF and Bv8: A novel family of tissue-restricted angiogenic factors","volume":"1654","author":"Ferrara","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jnci\/89.2.139","article-title":"Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma","volume":"89","author":"Gasparini","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib9","first-page":"5407","article-title":"High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer","volume":"61","author":"Foekens","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib10","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1158\/1078-0432.CCR-0951-3","article-title":"Association between HER-2\/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients","volume":"10","author":"Konecny","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib11","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1200\/JCO.2000.18.7.1423","article-title":"Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment","volume":"18","author":"Linderholm","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib12","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1158\/1078-0432.CCR-08-0593","article-title":"VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy","volume":"14","author":"Burstein","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1634\/theoncologist.5-suppl_1-37","article-title":"Prognostic value of vascular endothelial growth factor in breast cancer","volume":"5","author":"Gasparini","year":"2000","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib14","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.1998.16.9.3121","article-title":"Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma","volume":"16","author":"Linderholm","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib15","first-page":"101","article-title":"Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy","volume":"5","author":"Gasparini","year":"1999","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.breast.2008.02.010","article-title":"Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer","volume":"17","author":"Linderholm","year":"2008","journal-title":"Breast"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdp062","article-title":"Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer","author":"Linderholm","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12032-008-9157-9","article-title":"Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and\/or with an increased expression of vascular endothelial growth factor","volume":"26","author":"Linderholm","year":"2009","journal-title":"Med Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ygyno.2006.09.031","article-title":"The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma","volume":"104","author":"Mylona","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib20","unstructured":"Taha FM, Zeeneldin AA, Helal AM, et\u00a0al. Prognostic value of serum vascular endothelial growth factor in Egyptian females with metastatic triple negative breast cancer. Clin Biochem. In press."},{"key":"10.1016\/j.ijrobp.2010.07.031_bib21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ijc.11662","article-title":"Differential regulation of VEGF, HIF1alpha and angiopoietin-1, -2 and -4 by hypoxia and ionizing radiation in human glioblastoma","volume":"108","author":"Lund","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11060-004-4204-7","article-title":"Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines\u2014A clue to radioresistance?","volume":"74","author":"Hovinga","year":"2005","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib23","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.ijrobp.2006.07.1379","article-title":"Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT)","volume":"66","author":"Pejavar","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0360-3016(90)90005-5","article-title":"Regional nodal irradiation in the conservative treatment of breast cancer","volume":"19","author":"Haffty","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib25","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/cncr.23881","article-title":"Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer","volume":"113","author":"Moran","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib26","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/labinvest.3780204","article-title":"Validation of tissue microarray technology in breast carcinoma","volume":"80","author":"Camp","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib27","first-page":"24","article-title":"Tissue microarray: A new technology for amplification of tissue resources","volume":"7","author":"Rimm","year":"2001","journal-title":"Cancer J"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1096-9896(1998110)186:3<313::AID-PATH188>3.0.CO;2-X","article-title":"Expression of VEGF in routinely fixed material using a new monoclonal","volume":"186","author":"Turley","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib29","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2000.18.10.2046","article-title":"Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma","volume":"18","author":"Smith","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib30","first-page":"961","article-title":"Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer","volume":"1","author":"Toi","year":"1995","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib31","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/cncr.20500","article-title":"African-American\/white differences in breast carcinoma: p53 alterations and other tumor characteristics","volume":"101","author":"Jones","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/cncr.20501","article-title":"Breast carcinoma in African-American and white women: Application of molecular biology to understand outcome disparities","volume":"101","author":"Newman","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib33","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib34","first-page":"509","article-title":"Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment","volume":"20","author":"Wu","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib35","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/sj.bjc.6690755","article-title":"Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?","volume":"81","author":"Linderholm","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib36","first-page":"6363","article-title":"Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients","volume":"9","author":"Manders","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2407-2-8","article-title":"Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: Correlation with clinical features","volume":"2","author":"Feng","year":"2002","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib38","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/annonc\/mdi353","article-title":"Vascular endothelial growth factor (VEGF) expression is not associated with prognosis in patients with radically resected ampullary carcinoma","volume":"16","author":"Santini","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10549-005-9062-2","article-title":"Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy","volume":"96","author":"Kostopoulos","year":"2006","journal-title":"Breast Cancer Res Treatm"},{"key":"10.1016\/j.ijrobp.2010.07.031_bib40","unstructured":"Available from: www.nsabp.pitt.edu\/B40_Protocol_Brochure.pdf."},{"key":"10.1016\/j.ijrobp.2010.07.031_bib41","unstructured":"Available from: www.roche-trials.com\/patient\/trials\/trial110789.html."},{"key":"10.1016\/j.ijrobp.2010.07.031_bib42","unstructured":"Available from: www.clinicaltrials.gov\/ct2\/show\/NCT00625898."}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610009648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610009648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:41:02Z","timestamp":1759743662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610009648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0360301610009648"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.07.031","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Vascular Endothelial Growth Factor as a Prognostic Marker for Local Relapse in Early-Stage Breast Cancer Patients Treated With Breast-Conserving Therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}